Development and validation of a composite disease activity score for juvenile idiopathic arthritis.

OBJECTIVE To develop and validate a composite disease activity score for juvenile idiopathic arthritis (JIA), the Juvenile Arthritis Disease Activity Score (JADAS). METHODS The JADAS includes 4 measures: physician global assessment of disease activity, parent/patient global assessment of well-being, active joint count, and erythrocyte sedimentation rate. These variables are part of the American College of Rheumatology (ACR) Pediatric 30 (Pedi 30), Pedi 50, and Pedi 70 criteria for improvement. Validation analyses were conducted on >4,500 patients and included assessment of construct validity, discriminant validity, and responsiveness to change. Three versions of the JADAS were tested based on 71-joint (range 0-101), 27-joint (range 0-57), or 10-joint (range 0-40) counts. Statistical performances of the JADAS were compared with those of 2 rheumatoid arthritis composite scores, the Disease Activity Score in 28 joints (DAS28) and the Clinical Disease Activity Index (CDAI). RESULTS The JADAS demonstrated good construct validity, yielding strong correlations with JIA activity measures not included in the score and moderate correlations with the Childhood Health Assessment Questionnaire. Correlations obtained for the 3 JADAS versions were comparable, but superior to those yielded by the DAS28 and CDAI. The area under the curve of the JADAS predicted long-term disease outcome, measured as radiographic progression over 3 years. In 2 clinical trials, the JADAS discriminated well between ACR Pedi 30, Pedi 50, and Pedi 70 response and revealed strong responsiveness to clinical change. CONCLUSION The JADAS was found to be a valid instrument for assessment of disease activity in JIA and is potentially applicable in standard clinical care, observational studies, and clinical trials.

[1]  Jacob Cohen.  Statistical Power Analysis , 1992 .

[2]  A. Martini,et al.  Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritis , 2005, Annals of the rheumatic diseases.

[3]  J. Fries,et al.  Measurement of health status in children with juvenile rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[4]  D. Felson,et al.  Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.

[5]  A. Martini,et al.  Responsiveness of outcome measures in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. , 1999, Rheumatology.

[6]  Michael J. Miller,et al.  Minimal clinically important differences of the childhood health assessment questionnaire. , 2005, The Journal of rheumatology.

[7]  E. Giannini,et al.  Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. , 1996, Annals of the rheumatic diseases.

[8]  M H Liang,et al.  Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. , 1985, Arthritis and rheumatism.

[9]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[10]  J. Smolen,et al.  The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.

[11]  P. Tugwell,et al.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice. , 2003, Rheumatology.

[12]  A. Prieur,et al.  A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. , 2005, Arthritis and rheumatism.

[13]  A. Martini,et al.  Development and Testing of Reduced Joint Counts in Juvenile Idiopathic Arthritis , 2009, The Journal of Rheumatology.

[14]  M. A. van 't Hof,et al.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. , 1990, Annals of the rheumatic diseases.

[15]  A. Martini,et al.  Responsiveness of clinical measures in children with oligoarticular juvenile chronic arthritis. , 1999, The Journal of rheumatology.

[16]  Michael J. Miller,et al.  Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. , 2004, Arthritis and rheumatism.

[17]  M. Beresford,et al.  Juvenile Idiopathic Arthritis , 2011, Paediatric drugs.

[18]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[19]  A. Martini,et al.  Correlation between conventional disease activity measures in juvenile chronic arthritis , 1997, Annals of the rheumatic diseases.

[20]  R. Saurenmann,et al.  A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. , 2004, Arthritis and rheumatism.

[21]  A. Martini,et al.  Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[22]  A. N. Franzblau,et al.  A primer of statistics for non-statisticians. , 1958 .

[23]  A. Martini,et al.  Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease. , 2006, Arthritis and rheumatism.

[24]  M. Uffmann,et al.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score , 2005, Arthritis research & therapy.

[25]  R. Schneider,et al.  Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach. , 2005, Rheumatology.

[26]  N. Wulffraat,et al.  Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. , 2007, Arthritis and rheumatism.

[27]  A. Martini,et al.  Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. , 2006, Arthritis and rheumatism.